[Innovation approaches to treatment of children with malignant tumors of the musculoskeletal system].
The Department of Musculoskeletal System Tumors was formed in November 1989 within Research Institute of Pediatric Oncology and Hematology of N. N. Blokhin Russian Oncological Scientific Center of Russian Academy of Medical Sciences. Treatment is carried out with the newest achievements in oncopediatrics applied; priority is given to limb-sparing techniques. The total 5-year survival rate of patients with Ewing's sarcoma is 65.6%, the total 2-year survival rate of patients with soft tissue sarcomas is 62.2%, and the total 2-year survival rate of children with osteosarcoma is 76%. Study of complications and side-effects of chemotherapy, as well as the development of methods of their prevention and correction, present a separate direction in the department's activity. In 1999, the team of the institution's researchers was awarded Russian Federation State Prize for outstanding scientific achievements in the work Development and Clinical Application of Combined Methods of Treatment of Osteogenic Sarcoma. In 2003 and 2004, leading researcher N. M. Ivanova was awarded the institution's diplomas as a part of Biotech prize for the development of new methods of treatment of malignant tumors in children.
Ivanova
N M
NM
Aliev
M D
MD
Shvarova
A V
AV
Dzampaev
A Z
AZ
Mentkevich
G L
GL
D016026:Bone Marrow Transplantation / Q000379:methods*; D001859:Bone Neoplasms / Q000188:drug therapy*; D002648:Child; D003131:Combined Modality Therapy; D006801:Humans; D012512:Sarcoma, Ewing / Q000188:drug therapy / Q000628:therapy*